articleMolecular PsychiatrySep 14, 2020BRONZE OA

COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States

QQQuan Qiu WangDCDavid C. KaelberRXRong XuNDNora D. Volkow

Case Western Reserve University · MetroHealth · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

The global pandemic of COVID-19 is colliding with the epidemic of opioid use disorders (OUD) and other substance use disorders (SUD) in the United States (US). Currently, there is limited data on risks, disparity, and outcomes for COVID-19 in individuals suffering from SUD. This is a retrospective case-control study of electronic health records (EHRs) data of 73,099,850 unique patients, of whom 12,030 had a diagnosis of COVID-19. Patients with a recent diagnosis of SUD (within past year) were at significantly increased risk for COVID-19 (adjusted odds ratio or AOR = 8.699 [8.411–8.997], P

Citation impact

681
total citations
FWCI
95.65
Percentile
100%
References
27
Citations per year

Authors

4

Topics & keywords

Topics
Keywords
  • Coronavirus disease 2019 (COVID-19)
  • Health records
  • 2019-20 coronavirus outbreak
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Substance use
  • Medicine
  • Psychiatry
  • MEDLINE
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding